Prime Medicine (PRME) Current Assets (2021 - 2026)

Prime Medicine has reported Current Assets for 6 years, with the latest figure at $137.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 15.8% year-over-year to $137.9 million; the trailing twelve-month figure through Mar 2026 stood at $137.9 million (down 15.8% YoY), and the FY2025 full-year result was $181.3 million, down 14.44% from the prior year.
• Current Assets for Q1 2026 stood at $137.9 million, down from $181.3 million in the prior quarter.
• The five-year high for Current Assets was $296.6 million in Q4 2022, with the low at $121.3 million in Q2 2025.
• Historically, Current Assets has averaged $195.1 million across 5 years, with a median of $184.5 million in 2023.
• Annual changes were most pronounced in 2023 — Current Assets slumped 51.8% — and 2024, when it soared 48.2%.
• Prime Medicine's Current Assets stood at $296.6 million in 2022, then tumbled by 51.8% to $143.0 million in 2023, then soared by 48.2% to $211.9 million in 2024, then retreated by 14.44% to $181.3 million in 2025, then retreated by 23.94% to $137.9 million in 2026.
• The last three Current Assets figures came in at $137.9 million (Q1 2026), $181.3 million (Q4 2025), and $231.4 million (Q3 2025), per Business Quant data.